查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1789864

注射器市場規模、佔有率和趨勢分析報告：按用途、設計、應用、材料、最終用途、地區和細分市場預測，2025 年至 2033 年

Syringes Market Size, Share & Trends Analysis Report By Usage, By Design, By Application, By Material, By End Use, By Region And Segment Forecasts, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

注射器市場摘要

預計 2024 年全球注射器市場規模為 170.3 億美元，到 2033 年將達到 356.1 億美元，2025 年至 2033 年的複合年成長率為 8.66%。注射器的需求受到慢性疾病負擔加重、外科手術數量增加以及住院人數增加的推動。

此外，注射器技術的進步預計將推動市場成長。慢性病的流行及其導致的住院人數上升是主要的市場驅動力。根據世界衛生組織2024年12月發布的數據，2021年慢性病在全球奪走了至少4,300萬人的生命。此外，梅奧診所2024年2月發布的一項研究預測，到2030年，慢性病對全球帶來的經濟負擔預計將達到47兆美元。這一日益加重的負擔凸顯了對醫療用品（包括注射器）日益成長的需求，因為醫療保健系統正努力管理和治療這些長期疾病。

此外，住院患者和手術數量的增加將在未來幾年推動注射器的需求。隨著整形手術、心血管手術和整形外科手術等外科手術在各國和地區的普及，對注射器的需求也不斷成長。這些手術通常需要使用注射器進行麻醉和給藥，這導致整體需求激增。此外，手術技術的進步和患者數量的增加也推動了醫療保健機構對注射器的需求不斷成長。

預計未來幾年，對安全性的日益重視以及自動拆卸注射器的普及將推動市場成長。各公司正不斷利用這些先進的解決方案來創新其產品。例如，2024年3月，Hindusta注射器和醫療器材公司推出了Dispojekt，這是一款配備安全針的一次性注射器。這些注射器旨在降低醫護人員意外針刺傷（NSI）的風險，降低感染控制成本，最大限度地減少與處置和培訓相關的費用，並最終為醫療保健行業帶來長期經濟效益。

此外，疫苗接種和免疫接種需求的不斷成長也推動了注射器的需求，新參與企業正專注於生產自動防針刺注射器以滿足此需求。例如，根據VaccinesWork 2024年2月發布的數據，Revital Healthcare成為非洲第一個生產經世衛組織預先認證的一次性安全注射器的製造商。這些非洲製造的自動停用（AD）注射器正在加強整個非洲大陸的疫苗接種工作。在肯亞，免疫系統強烈建議使用AD注射器。 AD注射器的設計使其在單次注射後自動鎖定，防止重複使用，使其成為疫苗接種安全的黃金標準。

Revital Healthcare (EPZ) Limited 董事 Ronique R. Vora 表示：“預計整個肯亞大陸的注射器平均運輸時間將減少 80% 至 90%。”

「儘管印度是最大的注射器製造商，但我們還是突破了壁壘，將這些注射器出口到 35 多個國家，包括印度、四個歐洲國家和其他非洲國家，」沃拉說道，他也是肯亞衛生署瘧疾消除委員會和基金的創始成員之一。

預計此類疫苗注射器的製造和出口成長將在未來幾年推動市場成長。

請索取此報告的免費樣本以供參考。

此外，各種尺寸注射器的供應也支撐了市場的成長。下圖重點介紹了2022年和2023年幾種自動停用注射器的價格、尺寸和品牌名稱。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章注射器市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 注射器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章注射器市場：按用途的估計和趨勢分析

  • 細分儀表板
  • 全球注射器市場按用途變化分析
  • 全球注射器市場規模及趨勢分析（依用途，2021-2033）
  • 一次性注射器
  • 可重複使用的注射器

第5章注射器市場：設計估算與趨勢分析

  • 細分儀表板
  • 全球注射器市場設計差異分析
  • 全球注射器市場規模與趨勢分析（依設計，2021-2033 年）
  • 傳統注射器
  • 安全注射器
  • 預填充式注射器（PFS）
  • 智慧注射器

第6章注射器市場：按應用的估計和趨勢分析

  • 細分儀表板
  • 全球注射器市場趨勢分析（按應用）
  • 全球注射器市場規模及趨勢分析（按應用，2021-2033）
  • 疫苗和免疫接種
  • 過敏反應
  • 類風濕性關節炎
  • 糖尿病
  • 自體免疫疾病
  • 腫瘤學
  • 其他

第7章注射器市場：依材料估算與趨勢分析

  • 細分儀表板
  • 全球注射器市場材料波動分析
  • 全球注射器市場規模及趨勢分析（按材料，2021-2033）
  • 塑膠注射器
  • 玻璃注射器

第 8 章：注射器市場：依最終用途的估算與趨勢分析

  • 細分儀表板
  • 全球注射器市場按最終用途變化分析
  • 全球注射器市場規模與趨勢分析（依最終用途，2021-2033 年）
  • 直接競標
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 9 章注射器市場：區域估計和趨勢分析（按設計、用途、應用、材料和最終用途）

  • 區域儀表板
  • 2021-2033 年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Global Key company market share analysis, 2024
    • Revital
    • Hindustan Syringes &Medical Devices Ltd
    • Wuxi Yushou Medical Appliances Co., Ltd
    • Nipro Europe Group Companies
    • Abu Dhabi Medical Devices Company
    • B. Braun SE
    • BD
    • Sharps Technology, Inc.
    • Cardinal Health
    • Vita Needle Company
    • Terumo Europe NV
    • Taisei Kako Ltd
    • ulti med Products
    • Henke Sass Wolf GmbH
    • ITO CORPORATION
    • Retractable Technologies, Inc.
    • kohope.com
    • Al Shifa Medical Products Co
    • Liaoning Kangyi Medical Equipment Co., Ltd
    • CANE SPA
    • SMB Corporation of India
    • Lifelong Meditech Private Limited.
    • OSAKA CHEMICAL Co., Ltd
    • JMS Co.Ltd
    • APEX MEDICAL DEVICES
    • Cartel Health Care Pvt. Ltd
    • VEM Tooling Co., Ltd.（VEM Thailand Co., Ltd.）
    • Fresenius Kabi Canada Ltd
    • ICU Medical, Inc.
  • 熱圖分析/企業市場分析
  • 2024年企業市場佔有率預測分析
  • 其他主要市場公司名單
Product Code: GVR-4-68038-077-4

Syringes Market Summary

The global syringes market size was estimated at USD 17.03 billion in 2024 and is projected to reach USD 35.61 billion by 2033, growing at a CAGR of 8.66% from 2025 to 2033. The demand for syringes is rising owing to the increasing burden of chronic disorders, the rising number of surgical procedures, and the growing hospitalizations.

In addition, the advancements in syringes are anticipated to propel the market growth. The increasing prevalence of chronic diseases and the resulting hospitalizations are major market drivers. According to the data published by the WHO in December 2024, chronic diseases claimed the lives of at least 43 million people globally in 2021. In addition, a study published by the Mayo Clinic in February 2024 projects that the global economic burden of chronic diseases will reach an estimated USD 47 trillion by 2030. This growing burden underscores the rising demand for medical supplies, including syringes, as healthcare systems work to manage and treat these long-term conditions.

Furthermore, the rising number of hospitalizations and an increasing volume of surgical procedures drive the demand for syringes in the coming years. As surgical interventions, including cosmetic, cardiac, and orthopedic surgeries, become more prevalent across various countries and regions, the need for syringes grows. These surgeries often require the use of syringes for anesthesia and medication delivery, contributing to the overall surge in demand. Moreover, advancements in surgical techniques and a growing patient population further support this rising need for syringes in healthcare settings.

The growing emphasis on safety and auto-disable syringes is expected to propel market growth in the coming years. Companies are increasingly innovating their product offerings with these advanced solutions. For example, in March 2024, Hindusta Syringes and Medical Devices introduced the Dispojekt single-use syringes with safety needles. These syringes aim to reduce the risk of accidental needle-stick injuries (NSIs) among healthcare workers, lower infection control costs, and minimize expenses related to disposal and training, ultimately delivering long-term financial benefits to the healthcare sector.

Moreover, the growing demand for vaccinations and immunizations is driving the need for syringes, with new market entrants focusing on manufacturing auto-disable syringes to meet this demand. For example, according to data published by VaccinesWork in February 2024, Revital Healthcare has become the first African manufacturer of WHO-prequalified, single-use, safe syringes. These African-made auto-disable (AD) syringes enhance immunization efforts across the continent. In Kenya, the immunization system strongly advocates for AD syringes, which are developed to prevent reuse by locking automatically post single injection, making them the gold standard for vaccination safety.

"Average syringe transport times are expected to decrease by up to 80-90% on the continent". Said Roneek R. Vora, director, Revital Healthcare (EPZ) Limited

"We broke barriers by exporting these syringes to more than 35 countries, including India - despite India being a syringe production powerhouse -and four European countries, and to other African countries." Says Vora, who is also a founding member of the Kenyan Ministry of Health's End Malaria Council & Fund.

Such increasing manufacturing and export of auto-disabled syringes for vaccinations and immunizations is anticipated to propel market growth in the coming years.

To learn more about this report, request a free sample copy

In addition, the availability of syringes in various sizes supports market growth. The pictorial representation below highlights the prices of some auto-disabled syringes along with their size and brand name for 2022 and 2023.

Global Syringes Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global syringes market report based on design, usage, application, material, end use, and region:

  • Usage Outlook (Revenue, USD Million, 2021 - 2033)
  • Disposable Syringes
  • Reusable Syringes
  • Design Outlook (Revenue, USD Million, 2021 - 2033)
  • Conventional Syringes
  • Safety Syringes
    • Retractable Safety Syringes
    • Non-Retractable Safety Syringes
  • Prefilled Syringes (PFS)
  • Smart Syringes
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Vaccines and Immunizations
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Autoimmune Diseases
  • Oncology
  • Others
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Plastic Syringes
  • Glass Syringes
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Direct Tenders
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Design
    • 1.1.2. Usage
    • 1.1.3. Application
    • 1.1.4. Material
    • 1.1.5. End-use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Syringes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for vaccination and immunization
      • 3.2.1.2. Rising adoption of safety and prefilled syringes
      • 3.2.1.3. Increasing disease burden
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Rising production capacities for syringes
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Recalls of syringes
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Increasing development of auto-disable syringes
      • 3.2.3.3. Growth potential in emerging economies in syringes market
      • 3.2.3.4. Rising distribution partnerships
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Potential complications and risks associated with syringes
  • 3.3. Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Syringes Market: Usage Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Syringes Market Usage Movement Analysis
  • 4.3. Global Syringes Market Size & Trend Analysis, by Usage, 2021 to 2033 (USD Million)
  • 4.4. Disposable Syringes
    • 4.4.1. Disposable syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Reusable Syringes
    • 4.5.1. Reusable syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Syringes Market: Design Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Syringes Market Design Movement Analysis
  • 5.3. Global Syringes Market Size & Trend Analysis, by Design, 2021 to 2033 (USD Million)
  • 5.4. Conventional Syringes
    • 5.4.1. Conventional syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Safety Syringes
    • 5.5.1. Safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.1. Retractable Safety Syringes
        • 5.5.1.1.1. Retractable safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.2. Non-retractable Safety Syringes
        • 5.5.1.2.1. Non-retractable safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Prefilled Syringes (PFS)
    • 5.6.1. Prefilled syringes (PFS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Smart Syringes
    • 5.7.1. Smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Syringes Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Syringes Market Application Movement Analysis
  • 6.3. Global Syringes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Vaccines and Immunizations
    • 6.4.1. Vaccines and immunizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Anaphylaxis
    • 6.5.1. Anaphylaxis market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Rheumatoid Arthritis
    • 6.6.1. Rheumatoid arthritis market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Diabetes
    • 6.7.1. Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.9. Oncology
    • 6.9.1. Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Syringes Market: Material Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Syringes Market Material Movement Analysis
  • 7.3. Global Syringes Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
  • 7.4. Plastic Syringes
    • 7.4.1. Plastic syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Glass Syringes
    • 7.5.1. Glass syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Syringes Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Syringes Market End Use Movement Analysis
  • 8.3. Global Syringes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. Direct Tenders
    • 8.4.1. Direct tenders market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Hospital Pharmacies
    • 8.5.1. Hospital pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Retail Pharmacies
    • 8.6.1. Retail pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Online Pharmacies
    • 8.7.1. Retail pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Syringes Market: Regional Estimates & Trend Analysis By Design, By Usage, By Application, By Material, By End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. Reimbursement scenario
      • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Reimbursement scenario
      • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Reimbursement scenario
      • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Competitive scenario
      • 9.4.1.3. Regulatory framework
      • 9.4.1.4. Reimbursement scenario
      • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Reimbursement scenario
      • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Reimbursement scenario
      • 9.4.3.5. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Reimbursement scenario
      • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Reimbursement scenario
      • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Denmark
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Reimbursement scenario
      • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Reimbursement scenario
      • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Norway
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Reimbursement scenario
      • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Competitive scenario
      • 9.5.1.3. Regulatory framework
      • 9.5.1.4. Reimbursement scenario
      • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. India
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Reimbursement scenario
      • 9.5.2.5. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Reimbursement scenario
      • 9.5.3.5. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. South Korea
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Reimbursement scenario
      • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Reimbursement scenario
      • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Reimbursement scenario
      • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Competitive scenario
      • 9.6.1.3. Regulatory framework
      • 9.6.1.4. Reimbursement scenario
      • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Reimbursement scenario
      • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Competitive scenario
      • 9.7.1.3. Regulatory framework
      • 9.7.1.4. Reimbursement scenario
      • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Reimbursement scenario
      • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Reimbursement scenario
      • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. Reimbursement scenario
      • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
    • 10.2.1. Innovators
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Global Key company market share analysis, 2024
    • 10.3.4. Revital
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Design benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Hindustan Syringes & Medical Devices Ltd
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Design benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Wuxi Yushou Medical Appliances Co., Ltd
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Design benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Nipro Europe Group Companies
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Design benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Abu Dhabi Medical Devices Company
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Design benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. B. Braun SE
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Design benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. BD
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Design benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Sharps Technology, Inc.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Design benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Cardinal Health
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Design benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Vita Needle Company
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Design benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Terumo Europe NV
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Design benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. Taisei Kako Ltd
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Design benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. ulti med Products
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Design benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. Henke Sass Wolf GmbH
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Design benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. ITO CORPORATION
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Design benchmarking
      • 10.3.18.4. Strategic initiatives
    • 10.3.19. Retractable Technologies, Inc.
      • 10.3.19.1. Company overview
      • 10.3.19.2. Financial performance
      • 10.3.19.3. Design benchmarking
      • 10.3.19.4. Strategic initiatives
    • 10.3.20. kohope.com
      • 10.3.20.1. Company overview
      • 10.3.20.2. Financial performance
      • 10.3.20.3. Design benchmarking
      • 10.3.20.4. Strategic initiatives
    • 10.3.21. Al Shifa Medical Products Co
      • 10.3.21.1. Company overview
      • 10.3.21.2. Financial performance
      • 10.3.21.3. Design benchmarking
      • 10.3.21.4. Strategic initiatives
    • 10.3.22. Liaoning Kangyi Medical Equipment Co., Ltd
      • 10.3.22.1. Company overview
      • 10.3.22.2. Financial performance
      • 10.3.22.3. Design benchmarking
      • 10.3.22.4. Strategic initiatives
    • 10.3.23. CANE SPA
      • 10.3.23.1. Company overview
      • 10.3.23.2. Financial performance
      • 10.3.23.3. Design benchmarking
      • 10.3.23.4. Strategic initiatives
    • 10.3.24. SMB Corporation of India
      • 10.3.24.1. Company overview
      • 10.3.24.2. Financial performance
      • 10.3.24.3. Design benchmarking
      • 10.3.24.4. Strategic initiatives
    • 10.3.25. Lifelong Meditech Private Limited.
      • 10.3.25.1. Company overview
      • 10.3.25.2. Financial performance
      • 10.3.25.3. Design benchmarking
      • 10.3.25.4. Strategic initiatives
    • 10.3.26. OSAKA CHEMICAL Co., Ltd
      • 10.3.26.1. Company overview
      • 10.3.26.2. Financial performance
      • 10.3.26.3. Design benchmarking
      • 10.3.26.4. Strategic initiatives
    • 10.3.27. JMS Co.Ltd
      • 10.3.27.1. Company overview
      • 10.3.27.2. Financial performance
      • 10.3.27.3. Design benchmarking
      • 10.3.27.4. Strategic initiatives
    • 10.3.28. APEX MEDICAL DEVICES
      • 10.3.28.1. Company overview
      • 10.3.28.2. Financial performance
      • 10.3.28.3. Design benchmarking
      • 10.3.28.4. Strategic initiatives
    • 10.3.29. Cartel Health Care Pvt. Ltd
      • 10.3.29.1. Company overview
      • 10.3.29.2. Financial performance
      • 10.3.29.3. Design benchmarking
      • 10.3.29.4. Strategic initiatives
    • 10.3.30. VEM Tooling Co., Ltd. (VEM Thailand Co., Ltd.)
      • 10.3.30.1. Company overview
      • 10.3.30.2. Financial performance
      • 10.3.30.3. Design benchmarking
      • 10.3.30.4. Strategic initiatives
    • 10.3.31. Fresenius Kabi Canada Ltd
      • 10.3.31.1. Company overview
      • 10.3.31.2. Financial performance
      • 10.3.31.3. Design benchmarking
      • 10.3.31.4. Strategic initiatives
    • 10.3.32. ICU Medical, Inc.
      • 10.3.32.1. Company overview
      • 10.3.32.2. Financial performance
      • 10.3.32.3. Design benchmarking
      • 10.3.32.4. Strategic initiatives
  • 10.4. Heat Map Analysis/ Company Market Position Analysis
  • 10.5. Estimated Company Market Share Analysis, 2024
  • 10.6. List of Other Key Market Players

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America syringes market, by country, 2021 - 2033 (USD Million)
  • Table 4. North America syringes market, by design, 2021 - 2033 (USD Million)
  • Table 5. North America syringes market, by material, 2021 - 2033 (USD Million)
  • Table 6. North America syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 7. North America syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 8. North America syringes market, by application, 2021 - 2033 (USD Million)
  • Table 9. U.S. syringes market, by design, 2021 - 2033 (USD Million)
  • Table 10. U.S. syringes market, by material, 2021 - 2033 (USD Million)
  • Table 11. U.S. syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 12. U.S. syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 13. U.S. syringes market, by application, 2021 - 2033 (USD Million)
  • Table 14. Canada syringes market, by design, 2021 - 2033 (USD Million)
  • Table 15. Canada syringes market, by material, 2021 - 2033 (USD Million)
  • Table 16. Canada syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 17. Canada syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 18. Canada syringes market, by application, 2021 - 2033 (USD Million)
  • Table 19. Mexico syringes market, by design, 2021 - 2033 (USD Million)
  • Table 20. Mexico syringes market, by material, 2021 - 2033 (USD Million)
  • Table 21. Mexico syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 22. Mexico syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 23. Mexico syringes market, by application, 2021 - 2033 (USD Million)
  • Table 24. Europe syringes market, by country, 2021 - 2033 (USD Million)
  • Table 25. Europe syringes market, by material, 2021 - 2033 (USD Million)
  • Table 26. Europe syringes market, by design, 2021 - 2033 (USD Million)
  • Table 27. Europe syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 28. Europe syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 29. Europe syringes market, by application, 2021 - 2033 (USD Million)
  • Table 30. UK syringes market, by design, 2021 - 2033 (USD Million)
  • Table 31. UK syringes market, by material, 2021 - 2033 (USD Million)
  • Table 32. UK syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 33. UK syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 34. UK syringes market, by application, 2021 - 2033 (USD Million)
  • Table 35. Germany syringes market, by design, 2021 - 2033 (USD Million)
  • Table 36. Germany syringes market, by material, 2021 - 2033 (USD Million)
  • Table 37. Germany syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 38. Germany syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 39. Germany syringes market, by application, 2021 - 2033 (USD Million)
  • Table 40. France syringes market, by design, 2021 - 2033 (USD Million)
  • Table 41. France syringes market, by material, 2021 - 2033 (USD Million)
  • Table 42. France syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 43. France syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 44. France syringes market, by application, 2021 - 2033 (USD Million)
  • Table 45. Italy syringes market, by design, 2021 - 2033 (USD Million)
  • Table 46. Italy syringes market, by material, 2021 - 2033 (USD Million)
  • Table 47. Italy syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 48. Italy syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 49. Italy syringes market, by application, 2021 - 2033 (USD Million)
  • Table 50. Spain syringes market, by design, 2021 - 2033 (USD Million)
  • Table 51. Spain syringes market, by material, 2021 - 2033 (USD Million)
  • Table 52. Spain syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 53. Spain syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Spain syringes market, by application, 2021 - 2033 (USD Million)
  • Table 55. Denmark syringes market, by design, 2021 - 2033 (USD Million)
  • Table 56. Denmark syringes market, by material, 2021 - 2033 (USD Million)
  • Table 57. Denmark syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 58. Denmark syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 59. Denmark syringes market, by application, 2021 - 2033 (USD Million)
  • Table 60. Sweden syringes market, by design, 2021 - 2033 (USD Million)
  • Table 61. Sweden syringes market, by material, 2021 - 2033 (USD Million)
  • Table 62. Sweden syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 63. Sweden syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 64. Sweden syringes market, by application, 2021 - 2033 (USD Million)
  • Table 65. Norway syringes market, by design, 2021 - 2033 (USD Million)
  • Table 66. Norway syringes market, by material, 2021 - 2033 (USD Million)
  • Table 67. Norway syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 68. Norway syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 69. Norway syringes market, by application, 2021 - 2033 (USD Million)
  • Table 70. Asia Pacific syringes market, by country, 2021 - 2033 (USD Million)
  • Table 71. Asia Pacific syringes market, by material, 2021 - 2033 (USD Million)
  • Table 72. Asia Pacific syringes market, by design, 2021 - 2033 (USD Million)
  • Table 73. Asia Pacific syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 74. Asia Pacific syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 75. Asia Pacific syringes market, by application, 2021 - 2033 (USD Million)
  • Table 76. China syringes market, by design, 2021 - 2033 (USD Million)
  • Table 77. China syringes market, by material, 2021 - 2033 (USD Million)
  • Table 78. China syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 79. China syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 80. China syringes market, by application, 2021 - 2033 (USD Million)
  • Table 81. Japan syringes market, by design, 2021 - 2033 (USD Million)
  • Table 82. Japan syringes market, by material, 2021 - 2033 (USD Million)
  • Table 83. Japan syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 84. Japan syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 85. Japan syringes market, by application, 2021 - 2033 (USD Million)
  • Table 86. India syringes market, by design, 2021 - 2033 (USD Million)
  • Table 87. India syringes market, by material, 2021 - 2033 (USD Million)
  • Table 88. India syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 89. India syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 90. India syringes market, by application, 2021 - 2033 (USD Million)
  • Table 91. South Korea syringes market, by design, 2021 - 2033 (USD Million)
  • Table 92. South Korea syringes market, by material, 2021 - 2033 (USD Million)
  • Table 93. South Korea syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 94. South Korea syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 95. South Korea syringes market, by application, 2021 - 2033 (USD Million)
  • Table 96. Australia syringes market, by design, 2021 - 2033 (USD Million)
  • Table 97. Australia syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 98. Australia syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 99. Australia syringes market, by application, 2021 - 2033 (USD Million)
  • Table 100. Thailand syringes market, by design, 2021 - 2033 (USD Million)
  • Table 101. Thailand syringes market, by material, 2021 - 2033 (USD Million)
  • Table 102. Thailand syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 103. Thailand syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 104. Thailand syringes market, by application, 2021 - 2033 (USD Million)
  • Table 105. Latin America syringes market, by country, 2021 - 2033 (USD Million)
  • Table 106. Latin America syringes market, by material, 2021 - 2033 (USD Million)
  • Table 107. Latin America syringes market, by design, 2021 - 2033 (USD Million)
  • Table 108. Latin America syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 109. Latin America syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 110. Latin America syringes market, by application, 2021 - 2033 (USD Million)
  • Table 111. Brazil syringes market, by design, 2021 - 2033 (USD Million)
  • Table 112. Brazil syringes market, by material, 2021 - 2033 (USD Million)
  • Table 113. Brazil syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 114. Brazil syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 115. Brazil syringes market, by application, 2021 - 2033 (USD Million)
  • Table 116. Argentina syringes market, by design, 2021 - 2033 (USD Million)
  • Table 117. Argentina syringes market, by material, 2021 - 2033 (USD Million)
  • Table 118. Argentina syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 119. Argentina syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 120. Argentina syringes market, by application, 2021 - 2033 (USD Million)
  • Table 121. Middle East & Africa syringes market, by country, 2021 - 2033 (USD Million)
  • Table 122. Middle East & Africa syringes market, by material, 2021 - 2033 (USD Million)
  • Table 123. Middle East & Africa syringes market, by design, 2021 - 2033 (USD Million)
  • Table 124. Middle East & Africa syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 125. Middle East & Africa syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 126. Middle East & Africa syringes market, by application, 2021 - 2033 (USD Million)
  • Table 127. South Africa syringes market, by design, 2021 - 2033 (USD Million)
  • Table 128. South Africa syringes market, by material, 2021 - 2033 (USD Million)
  • Table 129. South Africa syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 130. South Africa syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 131. South Africa syringes market, by application, 2021 - 2033 (USD Million)
  • Table 132. Saudi Arabia syringes market, by design, 2021 - 2033 (USD Million)
  • Table 133. Saudi Arabia syringes market, by material, 2021 - 2033 (USD Million)
  • Table 134. Saudi Arabia syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 135. Saudi Arabia syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 136. Saudi Arabia syringes market, by application, 2021 - 2033 (USD Million)
  • Table 137. UAE syringes market, by design, 2021 - 2033 (USD Million)
  • Table 138. UAE syringes market, by material, 2021 - 2033 (USD Million)
  • Table 139. UAE syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 140. UAE syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 141. UAE syringes market, by application, 2021 - 2033 (USD Million)
  • Table 142. Kuwait syringes market, by design, 2021 - 2033 (USD Million)
  • Table 143. Kuwait syringes market, by material, 2021 - 2033 (USD Million)
  • Table 144. Kuwait syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 145. Kuwait syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 146. Kuwait syringes market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Syringes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Syringes Market, for Usage, 2021 - 2033 (USD Million)
  • Fig. 15 Syringes Market, for Disposable Syringes, 2021 - 2033 (USD Million)
  • Fig. 16 Syringes Market, for Reusable Syringes, 2021 - 2033 (USD Million)
  • Fig. 17 Syringes Market, for Design, 2021 - 2033 (USD Million)
  • Fig. 18 Syringes Market, for Conventional Syringes, 2021 - 2033 (USD Million)
  • Fig. 19 Syringes Market, for Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 20 Syringes Market, for Retractable Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 21 Syringes Market, for Non-Retractable Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 22 Syringes Market, for Prefilled Syringes (PFS), 2021 - 2033 (USD Million)
  • Fig. 23 Syringes Market, for Smart Syringes, 2021 - 2033 (USD Million)
  • Fig. 24 Syringes Market, for Material, 2021 - 2033 (USD Million)
  • Fig. 25 Syringes Market, for Plastic Syringes, 2021 - 2033 (USD Million)
  • Fig. 26 Syringes Market, for Glass Syringes, 2021 - 2033 (USD Million)
  • Fig. 27 Syringes Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 28 Syringes Market, for Vaccines and Immunizations, 2021 - 2033 (USD Million)
  • Fig. 29 Syringes Market, for Anaphylaxis, 2021 - 2033 (USD Million)
  • Fig. 30 Syringes Market, for Rheumatoid Arthritis, 2021 - 2033 (USD Million)
  • Fig. 31 Syringes Market, for Diabetes, 2021 - 2033 (USD Million)
  • Fig. 32 Syringes Market, for Autoimmune Diseases, 2021 - 2033 (USD Million)
  • Fig. 33 Syringes Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 34 Syringes Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 35 Syringes Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 36 Syringes Market, for Direct Tenders, 2021 - 2033 (USD Million)
  • Fig. 37 Syringes Market, for Hospital Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 38 Syringes Market, for Retail Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 39 Syringes Market, for Online Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 40 Regional Outlook, 2024 & 2033
  • Fig. 41 North America Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 44 Mexico Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 45 Europe Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 46 Germany Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 47 UK Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 48 France Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 49 Italy Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 50 Spain Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 52 Sweden Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 53 Norway Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 55 Japan Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 56 China Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 57 India Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 58 Australia Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 59 South Korea Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 60 Thailand Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 61 Latin America Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 62 Brazil Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 64 Middle East and Africa Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait Syringes Market, 2021 - 2033 (USD Million)